Otsuka Holdings
4578.T
#628
Rank
ยฃ30.00 B
Marketcap
ยฃ57.27
Share price
0.63%
Change (1 day)
41.79%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2026 (TTM): ยฃ2.42 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are ยฃ16.95 Billion. In 2025 the company made an earning of ยฃ2.50 Billion, an increase over its 2024 earnings that were of ยฃ1.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ2.42 B-3%
2025 ยฃ2.50 B45.77%
2024 ยฃ1.71 B117.32%
2023 ยฃ0.78 B-20.93%
2022 ยฃ0.99 B-12.7%
2021 ยฃ1.14 B-19.92%
2020 ยฃ1.42 B13.9%
2019 ยฃ1.25 B52.07%
2018 ยฃ0.82 B11.22%
2017 ยฃ0.74 B-36.03%
2016 ยฃ1.15 B31.15%
2015 ยฃ0.88 B
2013 ยฃ1.83 B33.52%
2012 ยฃ1.37 B-4.65%
2011 ยฃ1.44 B45.53%
2010 ยฃ0.99 B